Financial Counselors Inc’s Dentsply Sirona XRAY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-26,645
| Closed | -$398K | – | 569 |
|
|
2025
Q1 | $398K | Sell |
26,645
-8,068
| -23% | -$143K | 0.01% | 454 |
|
|
2024
Q4 | $659K | Sell |
34,713
-205,999
| -86% | -$4.36M | 0.01% | 379 |
|
|
2024
Q3 | $6.51M | Buy |
240,712
+5,633
| +2% | +$144K | 0.1% | 173 |
|
|
2024
Q2 | $5.86M | Buy |
235,079
+16,503
| +8% | +$473K | 0.09% | 175 |
|
|
2024
Q1 | $7.25M | Buy |
218,576
+8,793
| +4% | +$300K | 0.12% | 158 |
|
|
2023
Q4 | $7.47M | Sell |
209,783
-8,368
| -4% | -$266K | 0.13% | 154 |
|
|
2023
Q3 | $7.45M | Buy |
218,151
+1,643
| +0.8% | +$62.5K | 0.15% | 147 |
|
|
2023
Q2 | $8.66M | Buy |
216,508
+168
| +0.1% | +$6.68K | 0.18% | 131 |
|
|
2023
Q1 | $8.5M | Buy |
216,340
+21,435
| +11% | +$787K | 0.18% | 135 |
|
|
2022
Q4 | $6.21M | Sell |
194,905
-1,269
| -0.6% | -$38.3K | 0.14% | 153 |
|
|
2022
Q3 | $5.56M | Buy |
196,174
+8,720
| +5% | +$298K | 0.14% | 151 |
|
|
2022
Q2 | $6.7M | Buy |
187,454
+7,245
| +4% | +$293K | 0.16% | 147 |
|
|
2022
Q1 | $8.87M | Buy |
180,209
+11,544
| +7% | +$610K | 0.18% | 135 |
|
|
2021
Q4 | $9.41M | Buy |
168,665
+5,215
| +3% | +$287K | 0.19% | 136 |
|
|
2021
Q3 | $9.49M | Buy |
163,450
+1,202
| +0.7% | +$74.1K | 0.2% | 130 |
|
|
2021
Q2 | $10.3M | Buy |
162,248
+1,816
| +1% | +$120K | 0.22% | 125 |
|
|
2021
Q1 | $10.2M | Buy |
160,432
+6,468
| +4% | +$375K | 0.24% | 122 |
|
|
2020
Q4 | $8.06M | Buy |
153,964
+15,700
| +11% | +$774K | 0.2% | 128 |
|
|
2020
Q3 | $6.05M | Buy |
138,264
+5,053
| +4% | +$223K | 0.18% | 137 |
|
|
2020
Q2 | $5.87M | Buy |
133,211
+6,888
| +5% | +$291K | 0.19% | 136 |
|
|
2020
Q1 | $4.91M | Buy |
126,323
+12,992
| +11% | +$662K | 0.22% | 127 |
|
|
2019
Q4 | $6.41M | Sell |
113,331
-668
| -0.6% | -$37.2K | 0.23% | 130 |
|
|
2019
Q3 | $6.08M | Buy |
113,999
+6
| +0% | +$322 | 0.24% | 125 |
|
|
2019
Q2 | $6.65M | Buy |
113,993
+1,996
| +2% | +$107K | 0.27% | 122 |
|
|
2019
Q1 | $5.55M | Buy |
111,997
+12,824
| +13% | +$565K | 0.24% | 130 |
|
|
2018
Q4 | $3.69M | Buy |
99,173
+45,204
| +84% | +$1.65M | 0.18% | 151 |
|
|
2018
Q3 | $2.04M | Buy |
53,969
+42,078
| +354% | +$1.75M | 0.09% | 209 |
|
|
2018
Q2 | $520K | Sell |
11,891
-25
| -0.2% | -$1.17K | 0.02% | 327 |
|
|
2018
Q1 | $599K | Sell |
11,916
-1,520
| -11% | -$89.5K | 0.03% | 315 |
|
|
2017
Q4 | $884K | Sell |
13,436
-96,332
| -88% | -$6.13M | 0.04% | 290 |
|
|
2017
Q3 | $6.57M | Buy |
109,768
+3,791
| +4% | +$225K | 0.32% | 103 |
|
|
2017
Q2 | $6.87M | Sell |
105,977
-611
| -0.6% | -$38.6K | 0.34% | 101 |
|
|
2017
Q1 | $6.66M | Sell |
106,588
-9,768
| -8% | -$588K | 0.34% | 100 |
|
|
2016
Q4 | $6.72M | Buy |
+116,356
| New | +$6.87M | 0.36% | 95 |
|
|
2016
Q2 | $6.28M | Buy |
101,152
+6,165
| +6% | +$379K | 0.38% | 92 |
|
|
2016
Q1 | $5.85M | Buy |
+94,987
| New | +$5.6M | 0.36% | 92 |
|
|
2015
Q2 | – | Sell |
-4,513
| Closed | -$230K | – | 470 |
|
|
2015
Q1 | $230K | Buy |
+4,513
| New | +$233K | 0.01% | 407 |
|
Other funds holding XRAY
CB
Financial Counselors Inc's XRAY Position: Q2 2025 in Review
Financial Counselors Inc sold out of Dentsply Sirona (XRAY) in Q2 2025, closing a stake of 26,645 shares — an estimated $398K sold.
Financial Counselors Inc first reported a position in XRAY in Q1 2015 and held it in 37 quarters. The position peaked at $10.3M in Q2 2021. 393 funds tracked by Wall St. Rank hold XRAY as of Q2 2025.
- Financial Counselors Inc reported no remaining Dentsply Sirona position as of Q2 2025 after selling out during the quarter.
- Financial Counselors Inc sold 26,645 Dentsply Sirona shares in Q2 2025, an estimated $398K.
- Financial Counselors Inc first reported a position in Dentsply Sirona in Q1 2015 and held it in 37 quarters.
- Financial Counselors Inc's Dentsply Sirona position peaked at $10.3M in Q2 2021.
- 393 funds tracked by Wall St. Rank held Dentsply Sirona as of Q2 2025.
Based on Financial Counselors Inc's 13F filing for Q2 2025, filed 1 Aug 2025.